COVID-19 trials registries data warehouse

 Return to trial list

Trial - ACTRN12621000031864


Column Value
Trial registration number ACTRN12621000031864
Full text link
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

First author
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Dr Anthony Byrne

Contact
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

anthony.byrne@svha.org.au

Registration date
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2021-01-15

Recruitment status
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not recruiting

Study design
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

RCT

Allocation
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Randomized

Design
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Parallel

Masking
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Blind label

Center
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

single-center

Study aim
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Long covid

Inclusion criteria
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

• Adult patients (>16 years) consented to the ADAPT cohort study with laboratory confirmed SARS-CoV-2 PCR positive (ACTRN12620000554965) • Long COVID-19 symptoms, defined as persistent symptoms of dyspnoea, chest pain or fatigue at follow up visit 4

Exclusion criteria
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

o Patients that are unwilling or unable to participate in the supervised telerehabilitation program o Those that have participated in a structured, supervised exercise program of at least 6 weeks in duration in the last 3 months (prior to enrollment in the Long COVID-19 rehabilitation study) o People with other comorbid conditions that would prohibit participation in exercise training such as unstable cardiovascular disease o People with pre-existing chronic lung disease (including COPD, bronchiectasis, interstitial lung disease) or chronic heart failure known to be amenable to pulmonary rehabilitation. This people will instead be referred to their local pulmonary or heart failure rehabilitation service o People who have an immediate family or household member already enrolled in this trial to limit potential contamination of groups. If this is the case, the person will be offered the opportunity to participate in the exercise program at a later date, if desired, but their data will not be included in the analysis.

Number of arms
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2

Funding
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

St Vincent's Hospital Sydney

Inclusion age min
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

16

Inclusion age max
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

100

Countries
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Australia

Type of patients
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Patients recovered from covid

Severity scale
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

N/A

Total sample size
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

32

primary outcome
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Exercise capacity measured by six minute walk test[Pre and post intervention (0 and 8 weeks)]

Notes
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Phase
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not reported

Arms
Last imported at : Jan. 21, 2021, 3:02 p.m.
Source : International Clinical Trials Registry Platform (ICTRP)

[{"arm_notes": "", "treatment_id": 584, "treatment_name": "Home-based virtual rehabililtation", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]